Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

Please Try Again

Password Hint : {{passwordHint}}

Remember me

Forgot Password?

News Focus

LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)

Bullboard - Stock Discussion Forum BioVaxys Technology Corp. BVAXF

Primary Symbol: C.BIOV

BioVaxys Technology Corp. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on improving patient lives with novel immunotherapies based on the DPX immune-educating technology platform and its HapTenix neoantigen tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization and other immunological fields. The Company's clinical... see more

Bullboard (CSE:BIOV)

View:

Post by venturetownon Nov 06, 2024 8:13am

BioVaxys to Participate in the US Government (BARDA)

Biovaxys will collaborate with top companies like AstraZeneca, Novavax, Ginko Bioworks, and others. This puts Biovaxys at the heart of vaccine innovation. The RRPV aims to accelerate the development ...more

Discussion

(0)
•••

Post by PressReleaseon Nov 05, 2024 5:00am

New Press Release - BioVaxys to Participate in the US Government Biomedical Advanced Research and Development Authority (BARDA) Rapid Response Partnership Vehicle (RRPV) Vaccine Development Consortium

VANCOUVER, BC, Nov. 5, 2024 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or the "Company") is pleased to announce that it has been invited to and joined The Rapid Response Partnership Vehicle (RRPV), a consortium of large and small biopharma...read article.

Energy Co Unveils Q3 2024 Results: Record Growth & Strategic Expansion

posted Nov 21, 2024 9:00am by Coelacanth Energy Inc.

In Q3 2024, Coelacanth started the construction of its planned $80.0 million infrastructure project that includes over 35 kilometers of pipelines and a facility to handle current behind pipe volumes and future expansions. Ultimately the facility will be able to handle approximately 16,000 boe/d of which Coelacanth has approximately 4,400 boe/d tested but shut-in at the 5-19 Two Rivers East pad ...read more

Post by javaman12on Nov 03, 2024 11:59pm

Are You Sellers Done Yet? Scared Are You? Halloween Is Over!

"...SpayVac is planning to soon commercialize fertility control vaccines for deer, horses and other animals that are also based on the patented liposome-based delivery-platform technology ...more

Comment by javaman12on Nov 02, 2024 9:35pm

RE:I sent this e-mail to James Passin Today!

I also sent a copy of my last e-mail (my e-mail to James Passin) to Ursula Bechert, DVM, PhD at SprayVac. [url=ursula@spayvac.com][/url] I know that I am doing a lot of speculating but how are we to ...more

Discussion

Post by javaman12on Nov 02, 2024 6:45pm

I sent this e-mail to James Passin Today!

"...Does this distinguished medical biotech researcher's connection with Toralgen (Dr.Rajagopalan) work at cross purposes with BioVaxys's approach to a better vaccine delivery system? Or ...more

Discussion

Post by frankmanon Oct 31, 2024 3:38pm

1.9 million shares traded all markets update

Sym-X Bid - Ask Last Chg %Ch Vol $Vol #Tr BIOV - C ATS 135.0 0.065 · 0.07 ...more

Comment by frankmanon Oct 31, 2024 3:15pm

RE:Heading for another 2 million share traded day all mkts

Getting closer to my stink bids by Christmas.

Discussion

Post by frankmanon Oct 31, 2024 3:10pm

Heading for another 2 million share traded day all mkts

Sym-X Bid - Ask Last Chg %Ch Vol $Vol #Tr BIOV - C ATS 8.0 0.065 · 0.07 ...more

Discussion

Post by frankmanon Oct 31, 2024 8:03am

News: BioVaxys' DPX Exhibits Superior Immune System ...

BioVaxys' DPX Exhibits Superior Immune System Activation Compared to Aqueous and Emulsion-Based Antigen Delivery Systems Study Results Position Company to Target Segments of $270B+ Multi ...more

(0)
•••

Post by PressReleaseon Oct 31, 2024 7:01am

New Press Release - BioVaxys' DPX Exhibits Superior Immune System Activation Compared to Aqueous and Emulsion-Based Antigen Delivery Systems

Study Results Position Company to Target Segments of $270B+ Multi-Billion Dollar Drug Delivery Systems Market1VANCOUVER, BC, Oct. 31, 2024 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or the "Company") highlights studies showing that its novel immune...read article.

Comment by javaman12on Oct 30, 2024 9:04pm

RE:RE:RE:On the other hand the CEO sees a market cap in the billions

As a followup to my previous commentary and speculation, regarding BioVaxys CEO James Passin's suggestion that IMV may have gone bankrupt because they may have refused to partner with a bigger ...more

Discussion

Comment by javaman12on Oct 30, 2024 7:50pm

RE:RE:RE:On the other hand the CEO sees a market cap in the billions

I sent this post to the BioVaxys PR department. Maybe they wiil get a laugh from this or maybe it's an idea that they may have never previously considered? Is this a flippant notion or is it a ...more

Discussion

Comment by javaman12on Oct 30, 2024 7:10pm

RE:RE:On the other hand the CEO sees a market cap in the billions

Actually the Emerging Growth Conference was today October 30. It is already posted on Utube. Nothing is really too new here except that the CEO mentioned that he has no interest in doing any roll ...more

Discussion

Comment by frankmanon Oct 30, 2024 4:46pm

RE:RE:On the other hand the CEO sees a market cap in the billions

Trading volume (all markets) today over 2 million shares (2,382.8) hopefully stoked some buying interest from the conference. I plan on re connecting with CEO Passin soon. Whenever you speak with him ...more

Discussion

The Market Update

< Previous bulletin

Next bulletin >

A daily snapshot of everything
from market open to close.

< Previous

Next >

Dealroom for high-potential pre-IPO opportunities

Become a member today, It's free!

Sign In

Send my password

Become a member today, It's free!

Bullboard - Stock Discussion Forum BioVaxys Technology Corp. BVAXF

Primary Symbol: C.BIOV

Join the community and start posting on the bullboards today. It's free.

Create a portfolio watchlist today. It's free.

Bullboard (CSE:BIOV)